Simulations Plus, Inc.

NASDAQ:SLP

Medical - Healthcare Information Services

Healthcare
$18.50 +0.11%

+$0.02 today

Market cap
$374.16M
Beta
1.32
P/E (TTM)
-5.9
EPS (TTM)
-$3.12
52W Low $11.09High $21.01

Volume 0.00M

Average 0.35M

SLP Cash & Equivalents

Cash on hand and highly liquid investments that can be converted to cash almost immediately.

Simulations Plus, Inc.NASDAQ: SLP

Cash & Equivalents · Q2 FY2026 · quarter ended Feb 2026

Cash & equivalents rises 134.1% from a year ago

Cash & equivalents stood at $25.73M at the end of Q2 FY2026, up 134.1% from a year earlier and down 14.8% from the prior quarter. Over 3 fiscal years it compounded at -15.7% a year.

Context

  • Cash & equivalents amounted to 17.6% of total assets at the end of Q2 FY2026, up 12.1 pp from a year earlier.
  • Cash & equivalents increased in 2 of the last 3 fiscal years.

What to watch

Whether cash & equivalents keeps rising in the next quarterly balance sheet after a +134.1% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterFeb 2026
$25.73M-14.8% QoQ
Last fiscal yearAug 2025
$30.85M+199.2% YoY
Year agoFeb 2025
$10.99M+134.1% since
Cash & Equivalents past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+134.1%——
1 year+199.2%——
3-year CAGR-15.7%——
5-year CAGR——
10-year CAGR——

Cash & Equivalents history

USD · from the balance sheet

Latest · FY2025
30.85M USD
Year-over-year change
+199.2%
4-year CAGR
-4.4%

Cash & Equivalents vs competitors

How SLP compares with its peers on the latest reported figures

  • Peers report in different currencies, so cash & equivalents is compared through growth and share of total assets rather than absolute size.
  • Its year-over-year change of +134.1% is the 2nd highest of 11, against a peer median of +1.4%.
  • Cash & equivalents amounts to 17.6% of total assets for SLP, versus a peer median of 13.0%.
SLP Competitors
Cash & Equivalents for SLP and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
ANROAlto Neuroscience, Inc.Mar 2026$263.76M USD+64.1%+54.0%95.5%
DHDefinitive Healthcare Corp.Mar 2026$157.65M USD+48.6%+3.7%30.6%
AGLAgilon Health, Inc.Mar 2026$139.99M USD+1.0%-28.0%9.3%
SOPHSOPHiA GENETICS S.A.Mar 2026$65.39M USD-4.6%-24.2%41.7%
KRROKorro Bio, Inc.Mar 2026$61.7M USD-3.8%-16.1%33.6%
NAKANakamoto Inc.Mar 2026$35.3M USD+2994.9%+394.4%5.7%
CLLSCellectis S.A.Mar 2026$35M USD-72.6%-10.9%12.1%
SLPSimulations Plus, Inc.Feb 2026$25.73M USD+134.1%-15.7%17.6%
OPRXOptimizeRx CorporationMar 2026$20.17M USD+21.7%+8.7%12.1%
ACIUAC Immune S.A.Mar 2026CHF 19.17M CHF-4.0%-5.3%13.9%
NRCNational Research CorporationMar 2026$2.55M USD+1.8%-45.1%1.9%
Peer median (excluding SLP) —+1.4%-8.1%13.0%

Competitors are the stored peer set for SLP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Aug 2021
FY2022
Aug 2022
FY2023
Aug 2023
FY2024
Aug 2024
FY2025
Aug 2025
Cash & Equivalents36.98M51.57M57.52M10.31M30.85M
Short-term Investments86.62M76.67M57.94M9.94M1.5M
Net Receivables13.05M13.79M10.2M9.14M14.62M
Inventory1.01M1.39M804K00
Other Current Assets1.65M3.38M3.9M7.75M2.8M
Total Current Assets139.31M146.79M130.37M39.34M51.55M
Property, Plant & Equipment (Net)3.11M2.05M1.92M1.84M1.29M
Goodwill12.92M12.92M19.1M96.08M43.72M
Intangible Assets24.58M26.18M32.85M58.84M29.21M
Long-term Investments00000
Tax Assets1.64M2.12M7.98M11M4.77M
Other Non-current Assets51K439K425K542K1.4M
Total Non-current Assets42.3M43.71M62.27M168.3M80.39M
Total Assets181.61M190.5M192.64M207.64M131.94M
Account Payables387K225K144K602K470K
Short-term Debt382K461K442K475K206K
Tax Payables1.01M1.39M804K2.2M1.78M
Deferred Revenue651K2.86M3.1M2M2.7M
Other Current Liabilities10.15M931K3.91M4.48M1.34M
Total Current Liabilities11.57M7.74M11.99M12.07M6.73M
Long-term Debt00000
Deferred Tax Liabilities3.36M3.58M6.54M12.61M0
Deferred Revenue (Non-current)00000
Other Non-current Liabilities003.33M00
Total Non-current Liabilities4.26M4.52M10.62M13.14M410K
Total Liabilities15.83M12.26M22.61M25.21M7.14M
Common Stock133.42M138.51M144.97M20K20K
Retained Earnings32.41M40.04M25.2M30.35M(34.36M)
Accumulated OCI(43K)(308K)(141K)(251K)(271K)
Other Stockholders Equity00000
Minority Interest00000
Total Equity165.78M178.25M170.03M182.43M124.8M
Total Debt1.28M1.4M1.2M1.01M616K
Net Debt(35.71M)(50.16M)(56.33M)(9.31M)(30.24M)

Simulations Plus, Inc.

NASDAQ:SLP

Intrinsic Alpha fair value

Locked

Current Price

$18.50

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.